Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers.

Si'Ana A CogginsEric D LaingCara H OlsenEmilie GoguetMatthew MoserBelinda M Jackson-ThompsonEmily C SamuelsSimon D PollettDavid R TribbleJulian DaviesLuca IllinikMonique Hollis-PerrySantina E MaiolatesiChristopher A DuplessisKathleen F RamseyAnatalio E ReyesYolanda AlcortaMimi A WongGregory WangOrlando OrtegaEdward ParmeleeAlyssa R LindroseAndrew L SnowAllison M W MalloyAndrew G LetiziaDaniel EwingJohn H PowersKevin L SchullyTimothy H BurgessChristopher C BroderEdward Mitre

Published in: Open forum infectious diseases (2021)

Lack of postvaccination symptoms after receipt of the BNT162b2 vaccine does not equate to lack of vaccine-induced antibodies 1 month after vaccination.

Keyphrases

coronavirus disease
sars cov
high glucose
diabetic rats
endothelial cells
binding protein
stress induced